| Patents for C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826) |
|---|
| 07/27/2005 | EP1556059A1 Thrombopoietin mimetics |
| 07/27/2005 | CN1646540A Functionalized ionic liquids, and methods of use thereof |
| 07/21/2005 | US20050159469 HIV protease inhibiting compounds |
| 07/21/2005 | US20050159415 Agents for preventing or ameliorating insulin resistance and /or obesity |
| 07/19/2005 | US6919462 Using 1-aryl-3-cyano-5-aminopyrazole compound |
| 07/14/2005 | WO2005063689A1 Benzamide derivative |
| 07/14/2005 | WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153366 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 07/13/2005 | EP1551796A1 Improved syntheton synthesis |
| 07/13/2005 | CN1639172A Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/07/2005 | WO2005061487A1 Hiv protease inhibiting compounds |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | WO2005014530A3 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases |
| 07/07/2005 | US20050148665 caged non-steroidal ecdysome memetic; water soluble and accumulates in a host cell; biologically inactive until it is photochemically transformed by light |
| 07/06/2005 | EP1549685A1 Novel nitrosation polymer in organic synthesis |
| 07/06/2005 | EP1549609A2 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | CA2548571A1 Diacylhydrazine derivatives |
| 06/23/2005 | WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/14/2005 | US6905666 Heating to 60-120 degrees c in the presence of nickel-nickel oxide supported on silica/alumina and rhodium supported on carbon |
| 06/14/2005 | CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners |
| 06/09/2005 | WO2005051896A1 Nitroso derivatives of diphenylamine |
| 06/09/2005 | CA2547282A1 Nitroso derivatives of diphenylamine |
| 06/07/2005 | US6903237 Ectoparasitic insect pest controllers for animals and their usage |
| 05/26/2005 | US20050113567 Chemical intermediates for agricultural chemical of perfluoroisopropyl benzene derivtives and raw materials and agricultural compounds |
| 05/25/2005 | DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 05/19/2005 | WO2005012233A8 Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
| 05/19/2005 | WO2004078924A3 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/19/2005 | WO2004072254A3 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 05/19/2005 | DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/18/2005 | EP1185504B1 Stabilization of n-nitrosohydroxylamines by use of absorptive material |
| 05/17/2005 | US6894111 Organic electrochromic materials and polymers for optical attenuation in the near infrared region |
| 05/05/2005 | US20050096360 vascular adhesion protein; Allylhydrazine and hydroxylamine (aminooxy) compounds; inflammation, inflammatory diseases and autoimmune disorders, multiple sclerosis |
| 05/04/2005 | EP1246790B1 Substituted 1 and 2 naphthol mannich bases |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2129770C Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/07/2005 | WO2005030707A1 Reduced hydrazinopeptoids and use thereof in the treatment of cancer |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 03/31/2005 | WO2005012232A3 Hydrazide derivatives as prostaglandin receptors modulators |
| 03/23/2005 | EP1317415B1 Method for producing dnda |
| 03/23/2005 | CN1597664A Preparation method of high puring 1, 1-dimethyl by drazine |
| 03/16/2005 | EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/16/2005 | CN1594285A N-substituted aryloxy-oxalyl-N, N'-dihydrazide compounds and preparing process and application thereof |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/09/2005 | EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 02/17/2005 | WO2005014530A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases |
| 02/17/2005 | WO2005014528A1 Straight-chain and branched-chain lipid compounds as selective inhibitors of cyclooxygenase-2, anti-inflammatory agents, and anti-cancer agents |
| 02/17/2005 | CA2535403A1 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment of diseases |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506777A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient |
| 02/10/2005 | WO2005012233A1 Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
| 02/10/2005 | WO2005012232A2 Hydrazide derivatives as prostaglandin receptors modulators |
| 02/10/2005 | CA2529123A1 Hydrazide derivatives as prostaglandin receptors modulators |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/08/2005 | US6852890 Process for the preparation of phenylhydrazines |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 01/27/2005 | WO2005007614A1 Monoamine oxidase inhibitors |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/20/2005 | CA2535986A1 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | CN1185216C Fungicides |
| 01/06/2005 | US20050002835 Micro-engineered reactor |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/23/2004 | US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis |
| 12/08/2004 | EP1483276A1 Ferrocenyl ligands and the use thereof in catalysis |
| 12/08/2004 | EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 12/01/2004 | EP1480988A1 Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions |
| 12/01/2004 | EP1480944A2 Substituted aryl ketones |
| 12/01/2004 | CN1177813C 1,2-alkyl (aryl) acyl aroyl hydrazing insect growth regulator and its preparation and application |
| 11/25/2004 | US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis |
| 11/17/2004 | EP1476753A2 Functionalized compositions for improved immobilization |
| 11/10/2004 | EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives |
| 11/09/2004 | US6815561 Method for producing DNDA |
| 11/09/2004 | US6815528 Complex of ruthenium compound and polymer |
| 11/04/2004 | WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use |
| 10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/21/2004 | US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease |
| 10/20/2004 | CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/12/2004 | US6803479 Reagents and method for spatio-temporal control of gene expression by illumination |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 09/23/2004 | WO2004080492A1 Methods of radiofluorination of biologically active vectors |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | CA2518889A1 Methods of radiofluorination of biologically active vectors |
| 09/22/2004 | CN1531562A Photobase generators, curable compositions prepared by using same and process of curing |